Weight Loss · 4 min read
Semaglutide vs. tirzepatide: what is the difference?
Compare semaglutide and tirzepatide by how they work, approved products, side effects, and the questions that help guide a treatment decision.
By Peppy Care · Published · Updated
The short answer
Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on both GIP and GLP-1 receptors. Certain approved products support weight management, but the best choice depends on your health, risks, and access to ongoing care. The medicines are not interchangeable dose for dose.
How do semaglutide and tirzepatide work?
Both medicines affect pathways involved in appetite and blood sugar. GLP-1 means glucagon-like peptide-1. Semaglutide activates its receptor, which can reduce appetite and help regulate blood sugar.
Tirzepatide also activates the receptor for glucose-dependent insulinotropic polypeptide, or GIP. The FDA's Zepbound approval announcement explains this dual action. Having 2 targets does not, by itself, determine which medicine suits a particular person.
How do the approved products differ?
Approval applies to a specific product and use. A medicine for diabetes and a medicine for weight management may contain the same ingredient with different instructions.
| Question | Semaglutide | Tirzepatide |
|---|---|---|
| Which receptors does it act on? | GLP-1 | GIP and GLP-1 |
| Example of an approved weight-management product | Wegovy | Zepbound |
| Example of an approved diabetes product | Ozempic | Mounjaro |
| Can you substitute the same numerical dose? | No | No |
These examples do not list every approved use or formulation. Check the current prescribing information for the exact product your clinician discusses.
Which medicine leads to more weight loss?
A useful comparison needs the same patient population, follow-up period, and outcome measure. Separate trial headlines do not give you those conditions. A percentage quoted from a study also cannot predict your result.
Ask your clinician which evidence applies to your situation. Diabetes, other health conditions, side effects, and treatment interruptions can affect the decision. The NIDDK medication guide places medication within a broader plan for food, activity, and long-term care.
Choose a plan you can follow safely and consistently. A prescription that becomes unaffordable after an introductory offer needs a conversation before treatment starts.
What risks should you compare?
Both medicines can cause digestive symptoms. Each product also has warnings and reasons some people should not use it. Discuss your medical history, other medicines, pregnancy plans, and any previous reaction to treatment.
Ask how the team handles symptoms and changes in treatment. Do not combine or switch these medicines on your own. Read our guide to GLP-1 side effects before your appointment so you can ask specific questions.
Does a compounded version have the same approval?
No. The FDA does not approve compounded drugs before they reach patients. The same ingredient name does not establish the same finished product, evidence, or instructions.
Before you compare prices, confirm the product name, formulation, pharmacy, and reason for the proposed treatment. Our guide to compounded and approved medications explains that distinction. You can also review Peppy's GLP-1 treatment information before an individual clinician evaluation.
Frequently asked questions
Is tirzepatide a GLP-1 medicine?
Tirzepatide acts on both GIP and GLP-1 receptors. People often group it with GLP-1 medicines, but its dual action differs from semaglutide.
Can I switch from semaglutide to tirzepatide at the same dose?
No. The doses are not equivalent. Your prescriber must assess whether a switch is appropriate and give you instructions for the new product.
Does the same ingredient mean two products are identical?
No. Formulation, approval, intended use, and instructions can differ. Ask for the exact product name instead of comparing ingredient names alone.
How should I choose between semaglutide and tirzepatide?
Discuss the relevant evidence, medical risks, side effects, total cost, and follow-up with your clinician. No single option is best for everyone.
Sources
- NIDDK: Prescription medications to treat overweight and obesity
- FDA: Zepbound approval for chronic weight management
- FDA: Compounding questions and answers
Educational information from Peppy Care. Discuss your medical history, treatment options, and questions about the evidence with a licensed clinician.
Discuss your health goals.
Start an online intake. A licensed clinician determines whether treatment is appropriate.